BABA vs BNED

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no Altman Z-Score available, leaving bankruptcy risk unconfirmed but concerning given high leverage. Despite a low current P/E of 12.89 compared to sector average of 53.76, the negative forward P/E (-0.25) and collapsing earnings growth (-62% YoY) signal deteriorating profitability. The stock trades above the Graham Number of $11.53 but well above the intrinsic value of $4.97, suggesting overvaluation on a conservative basis. Persistent negative earnings surprises, declining ROE, and weak insider sentiment (40/100) further undermine confidence in a near-term turnaround.